Delivery Order #SPE2D626F99RQ

Delivery Order for Negative Control Supplies to DLA by Dove Medical Supply

This award represents a delivery order contract issued under an existing indefinite delivery, indefinite quantity (IDIQ) contract held by Dove Medical Supply LLC, a provider specializing in procuring and distributing essential medical supplies. The contract focuses on supplying negative control materials for various viral agents including influenza and SARS-CoV-2, crucial for laboratory diagnostic testing and quality control. This delivery order supports the Defense Logistics Agency’s ongoing commitment to ensuring reliable access to critical medical reagents, thereby enhancing the agency’s operational readiness and public health responsiveness. The scope covers the timely delivery of laboratory-grade negative control products to a designated location in Summerfield, North Carolina, fulfilling a specified need within a one-month period. Awarded through the existing competitively bid IDIQ contract, this delivery order leverages the previously vetted contractual framework, ensuring efficient procurement without the need for a new competitive process. The delivery timeline is set for a short-term period in early 2026, aligning with the operational demand cycles. This award complements the broader IDIQ scope that includes an extensive assortment of medical and laboratory supplies, supported by key subcontractors such as Smith Medical, Becton Dickinson, and Thermo Fisher Scientific, which collectively enhance the Defense Logistics Agency’s medical supply chain robustness.

Description

4571111350!FLU/RSV/SARS-COV-2 NEGATIVE CONTROL

View original record